Lyka Labs (LYKALABS) | Financial Analysis & Statements
Financial Overview
Latest Annual: 2025Income Metrics
Revenue
1.4B
Gross Profit
829.0M
59.86%
Operating Income
111.7M
8.06%
Net Income
79.3M
5.73%
Balance Sheet Metrics
Total Assets
1.8B
Total Liabilities
726.2M
Shareholders Equity
1.0B
Debt to Equity
0.70
Cash Flow Metrics
Operating Cash Flow
-28.2M
Free Cash Flow
-137.6M
Revenue & Profitability Trend
Lyka Labs Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 1.4B | 1.1B | 883.4M | 1.8B | 671.1M |
| Cost of Goods Sold | 555.9M | 451.9M | 378.7M | 533.0M | 381.8M |
| Gross Profit | 829.0M | 599.4M | 504.7M | 1.3B | 289.2M |
| Operating Expenses | 303.4M | 220.7M | 183.9M | 214.3M | 131.1M |
| Operating Income | 111.7M | 25.5M | 24.4M | 830.9M | 113.6M |
| Pre-tax Income | 111.2M | -9.3M | -131.7M | 592.5M | -141.4M |
| Income Tax | 31.9M | 16.9M | -187.0K | 208.0M | -40.5M |
| Net Income | 79.3M | -26.2M | -131.5M | 384.4M | -100.9M |
| EPS (Diluted) | - | -₹0.79 | -₹4.63 | ₹13.57 | -₹4.07 |
Income Statement Trend
Lyka Labs Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | 674.3M | 506.5M | 442.0M | 522.0M | 290.8M |
| Non-Current Assets | 1.1B | 1.1B | 1.1B | 1.3B | 1.6B |
| Total Assets | 1.8B | 1.6B | 1.5B | 1.9B | 1.9B |
| Liabilities | |||||
| Current Liabilities | 466.3M | 376.4M | 326.0M | 993.5M | 498.8M |
| Non-Current Liabilities | 259.9M | 508.2M | 732.5M | 727.7M | 1.7B |
| Total Liabilities | 726.2M | 884.6M | 1.1B | 1.7B | 2.2B |
| Equity | |||||
| Total Shareholders Equity | 1.0B | 682.7M | 456.7M | 134.9M | -250.9M |
Balance Sheet Composition
Lyka Labs Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 111.2M | -9.3M | -131.7M | 592.5M | -141.4M |
| Operating Cash Flow | -28.2M | -114.3M | -14.4M | 667.9M | 56.1M |
| Investing Activities | |||||
| Capital Expenditures | -123.4M | -92.3M | 63.1M | -75.1M | -12.7M |
| Investing Cash Flow | -122.6M | -92.3M | 63.1M | -75.1M | -12.7M |
| Financing Activities | |||||
| Dividends Paid | - | - | - | - | - |
| Financing Cash Flow | 320.0M | 308.3M | 333.8M | 95.8M | -96.9M |
| Free Cash Flow | -137.6M | -74.6M | 7.7M | 717.3M | 75.4M |
Cash Flow Trend
Lyka Labs Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
49.57
Price to Book
3.84
Price to Sales
2.84
Profitability Ratios
Profit Margin
5.79%
Operating Margin
7.98%
Return on Equity
9.23%
Return on Assets
4.19%
Financial Health
Current Ratio
1.45
Debt to Equity
37.83
Beta
0.55
Per Share Data
EPS (TTM)
₹2.22
Book Value per Share
₹28.64
Revenue per Share
₹38.38
Financial data is updated regularly. All figures are in the company's reporting currency.